Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash Flows From Operating Activities:
Net income	$ 38,167	$ 38,569
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	27,442	25,144
Provision for doubtful accounts receivable	5,474	5,001
Equity in earnings of unconsolidated investments	(3,924)	(5,069)
Distributions from unconsolidated investments	6,488	10,272
Gains on sale of restricted marketable securities	(449)	(172)
Deferred income taxes	(4,795)	(4,517)
Stock–based compensation	1,557	1,547
Changes in operating assets and liabilities, net of the effect of acquisitions:
Restricted Cash and Cash Equivalents	(8,897)	(6,033)
Accounts receivable	(8,485)	1,438
Income tax receivable	4,114	(5,953)
Inventories	(439)	(216)
Prepaid expenses and other assets	(228)	(705)
Trade accounts payable	230	557
Accrued payroll	(575)	(9,039)
Amounts due to third party payors	3,480	2,493
Other current liabilities and accrued risk reserves	2,674	2,764
Other noncurrent liabilities	726	1,106
Deferred revenue	770	759
Net cash provided by operating activities	63,330	57,946
Cash Flows From Investing Activities:
Additions to property and equipment	(38,953)	(36,727)
Investments in unconsolidated limited liability companies	$ (373)	(1,675)
Acquisition of non-controlling interest		(768)
Investments in notes receivable	$ (5,477)	(767)
Collections of notes receivable	333	3,046
Change in restricted cash and cash equivalents	7,423	6,256
Purchase of restricted marketable securities	(49,993)	(36,947)
Sale of restricted marketable securities	39,601	27,641
Net cash used in investing activities	(47,439)	(39,941)
Cash Flows From Financing Activities:
Tax benefit from stock–based compensation	585	201
Principal payments under capital lease obligations	(2,299)	(1,693)
Dividends paid to preferred stockholders	(6,502)	(6,502)
Dividends paid to common stockholders	(15,367)	(13,913)
Issuance of common shares	$ 8,231	6,757
Repurchase of common shares		(6,995)
Entrance fee deposits	$ (11)	(400)
Change in deposits	486	(248)
Net cash used in financing activities	(14,877)	(22,793)
Net Increase (Decrease) in Cash and Cash Equivalents	1,014	(4,788)
Cash and Cash Equivalents, Beginning of Period	69,767	81,705
Cash and Cash Equivalents, End of Period	$ 70,781	76,917
Supplemental disclosure of non-cash investing and financing activities:
Buildings, personal property, and obligations recorded under capital lease agreements		$ 39,032